SCHEMBL21473601

SCHEMBL21473601

COC(C)(C)CC(C)(C)C1CCNCC1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19033715 0.84 MEN1 (0.33)
SCHEMBL14051676 0.80 MEN1 (0.31)
SCHEMBL10487352 0.78 TDP1 (0.31) TDP1
SCHEMBL19033675 0.75 ARG1 (0.33)
SCHEMBL24737703 0.73
SCHEMBL19510058 0.73
SCHEMBL21473597 0.73 NCF1 (0.34) ALDH1A1TSHRTDP1
SCHEMBL26064874 0.73
SCHEMBL14212686 0.73 KDM4E (0.39) TDP1
SCHEMBL2673779 0.73 MEN1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3778586-A1 QUINAZOLINE COMPOUND SERVING AS EGFR TRIPLE MUTATION INHIBITOR AND APPLICATIONS THEREOF East China University of Science and Technology (CN) 2021-02-17 EP disclosed
WO-2019196938-A1 QUINAZOLINE COMPOUND SERVING AS EGFR TRIPLE MUTATION INHIBITOR AND APPLICATIONS THEREOF 华东理工大学 2019-10-17 WO disclosed